LncRNA HCP5 acts as a potential diagnostic biomarker and attenuates the inflammatory response in neonatal sepsis by targeting miR-138-5p/SIRT1
HCP5 could potentially serve as a diagnostic biomarker for NS and it may inhibit inflammation in NS by targeting miR-138-5p/SIRT1 axis. These findings highlight the potential role of HCP5 in the diagnosis and treatment of NS.
Authors
- Yong Luo (ORCID: https://orcid.org/0000-0002-7150-552X)
- Lei Yang (ORCID: https://orcid.org/0000-0002-6155-9268)
- Xiaohua Hu (ORCID: https://orcid.org/0000-0002-2161-1324)
- Shuisheng Yuan
- Anhui Hu
Institutions
- Xinyu University (CN)
Publication Details
- Journal
- Central European Journal of Immunology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.5114/ceji.2024.143462
- Citations
- 3
- Primary Topic
- Thermal Regulation in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 1.27